Alterity Therapeutics Limited
Financial ratios & Valuation

Forward Multiples (2026 – 2027)

20262027
Price/Earnings ratio
-5.08-69.65
Price/Sales ratio
44.81294.55
Earnings per Share (EPS)
$-0.99$-0.07

Historical Multiples (2015 – 2024)

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 TTM Median
Valuation Ratios
Price/Earnings ratio
-12.97-7.32-3.50-2.74-1.57-2.65-3.20-2.75-1.22-0.85-112.95-2.65
Price/Sales ratio
431.64397.15199.86112.87173.71N/A11.296.914.324.076.50K173.71
Price/Book Value ratio
1.951.801.111.411.132.431.600.990.741.1860.231.13
Price/Cash Flow ratio
-7.02-7.63-4.51-3.63-1.35-2.72-2.82-2.87-0.84-1.30N/A-1.35
Price/Free Cash Flow ratio
-7.00-7.63-4.49-3.59-1.35-2.72-2.82-2.85-0.84-1.29-123.68-2.72
Price/Earnings Growth ratio
0.20-0.301.45-0.28-0.060.050.190.06-0.180.10-0.070.05
Dividend Yield
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Profitability Indicator Ratios
Gross Profit Margin
-45.49%84.01%83.89%89.16%72.64%N/A91.70%92.88%92.72%94.66%-24.77%N/A
Operating Profit Margin
-5901.05%-6019.19%-5197.93%-3862.47%-11713.74%N/A-349.76%-302.56%-373.72%-487.69%-9521.94%-11713.74%
Pretax Profit Margin
-3327.86%-5418.27%-5696.60%-4108.75%-11367.29%N/A-352.78%-249.38%-349.86%-474.64%-5087.06%-11367.29%
Net Profit Margin
-3327.86%-5418.27%-5696.60%-4108.75%-11020.83%N/A-352.78%-250.74%-352.53%-475.79%-5759.47%-11020.83%
Effective Tax Rate
2.90%11.09%-8.75%5.99%3.04%3.60%26.95%-0.54%-0.76%-0.24%N/A3.60%
Return on Assets
-14.06%-22.91%-29.83%-44.14%-60.07%-72.88%-45.58%-31.05%-50.54%-99.47%-44.89%-60.07%
Return On Equity
-15.04%-24.64%-31.83%-51.40%-72.25%-91.93%-50.24%-36.22%-60.52%-138.59%-44.34%-72.25%
Return on Capital Employed
-26.67%-27.37%-29.04%-48.31%-76.63%-98.33%-49.73%-43.61%-63.81%-141.52%-88.00%-98.33%
Liquidity Ratios
Current Ratio
15.3514.2715.877.055.983.6210.91N/AN/AN/A6.345.98
Quick Ratio
15.3514.1715.726.955.794.6610.917.066.173.546.195.79
Cash ratio
12.8412.1213.765.764.333.389.165.983.592.354.844.33
Days of Sales Outstanding
13.46K12.24K8.36K5.71K16.24KN/A347.06332.64806.06367.039.92KN/A
Days of Inventory outstanding
10.444.01K4.13K4.30K7.64K1.84K0.00N/AN/AN/AN/A1.84K
Operating Cycle
13.47K16.26K12.50K10.01K23.88KN/A347.06332.64806.06367.032.44KN/A
Days of Payables Outstanding
514.224.98K1.11K22.33K20.81K3.09K1.46K2.63K2.19K989.787.89K7.89K
Cash Conversion Cycle
12.95K11.27K11.39K-12.31K3.06KN/A-1.12K-2.30K-1.39K-622.752.03KN/A
Debt Ratios
Debt Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/A0.15N/A
Debt Equity Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/A0.18N/A
Long-term Debt to Capitalization
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Total Debt to Capitalization
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Interest Coverage Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Cash Flow to Debt Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Company Equity Multiplier
1.061.071.061.161.201.261.101.161.191.391.181.26
Cash Flow Ratios
Operating Cash Flow / Sales Ratio
-61.47-52.00-44.29-31.04-128.57N/A-3.99-2.40-5.11-3.13N/A-128.57
Free Cash Flow / Operating Cash Flow Ratio
1.001.001.001.001.001.001.001.001.001.00N/A1.00
Cash Flow Coverage Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Short Term Coverage Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Dividend Payout Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A